Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 166 participants.
Also called NCT02286258
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Phase 1/2
- Enrolled
- 166 participants
- Registry
-
NCT02286258
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Terminated
Technical summary
Registry record NCT02286258. Non-randomized; no masking; primary purpose diagnostic. Start 2014-10 (actual); primary completion 2017-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
- Acronym
- MultiGFR
- Condition
- Renal Insufficiency, Chronic
- Condition
- Kidney Diseases
- Intervention (Drug)
- Calcium EDTA
- Intervention (Drug)
- Gd-DOTA
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Ministry of Health, France
Record details
- Record id
cardio:ct-nct02286258- Content hash
f34c4ef400256e562d1f3eee247609dcb2d388d0024b810fe1461c42fd638a57